Weibing Ding, PhDDirector at GSK
Weibing Ding is a Director at GSK’s Biopharm Division. Since obtained his Ph.D. in Chemical Engineering from the University of Utah, Dr. Ding has spent more than 20 years with both single-use technology (SUT) provider and drug manufacturers. He has been instrumental in development, manufacturing, qualification and implementation of SUT in commercial bioprocesses. Prior to joining GSK, Dr. Ding worked for Amgen where he contributed to advancement of material science and technology, and industrialization of SUT in biomanufacturing. He has been driving for standardization of SUT across the industry, and is currently an Expert Panel member for development of USP<665>.